Structure Info
- Chemspace ID
- CSSS00025762901 (In-Stock Screening Compounds)
- MFCD
- MFCD00877177
- IUPAC Name
- 3-methoxy-6-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]benzene-1,2-diol
- Mol formula
- C18H20O6
- Mol weight
- 332 Da
- Catalog Number(s)
- 109971-63-3, 19750, A019089046, AA00JRL7, ACM109971633, AD248275, AG00JRNZ, AG305878, AGN-PC-0NX9WH, AJ22119, AR00JSCZ, BD17499, CD12180812, CSC025762901, G12824, HY-121993, LN03248914, MS-24999, T36848, Y3123506, ZXC239805
- Zoom the structure
- CSSS00025762901
Items Overall 13 items from 3 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 97 | 5 mg | 100 | |
MedChemExpress | 10 days | United States To: | 97 | 10mM/1mL | 110 | |
Description: Names: Combretastatin A-1; Product Description: Combretastatin A-1 is a microtubule polymerization inhibitor that binds to the colchicine-binding site of tubulin. Combretastatin A-1 inhibits the Wnt/β-catenin pathway through tubulin depolymerization mediated AKT deactivation. Combretastatin A-1 exhibits anti-tumor and anti-vascular effects .; Target: Microtubule/Tubulin; CAS: 109971-63-3 | ||||||
Show all items | ||||||
MedChemExpress EU | 10 days | Sweden To: | 97 | 5 mg | 105 | |
MedChemExpress EU | 10 days | Sweden To: | 97 | 10mM/1mL | 116 | |
Description: Names: Combretastatin A-1; Product Description: Combretastatin A-1 is a microtubule polymerization inhibitor that binds to the colchicine-binding site of tubulin. Combretastatin A-1 inhibits the Wnt/β-catenin pathway through tubulin depolymerization mediated AKT deactivation. Combretastatin A-1 exhibits anti-tumor and anti-vascular effects; Target: Microtubule/Tubulin;Wnt; CAS: 109971-63-3 | ||||||
Show all items | ||||||
Targetmol Chemicals Inc | 30 days | United States To: | 97 | 1 mg | 35 | |
Description: Combretastatin A-1 is a potent microtubule inhibitor with anti-tumour and anti-vascular activity, acting through microtubule protein depolymerisation-mediated inactivation of AKT to inhibit the Wnt/β-catenin pathway, and can be used to study hepatocellular carcinoma.; CAS: 109971-63-3 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire